T-cell Leukemia Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Leukemia Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma [Phase 2]
Phase 2 trial of nivolumab in HTLV-1–associated adult T-cell leukemia/lymphoma has completed and results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) [Phase 2]
Phase 2 trial update on KW-0761 (mogamulizumab) in adults with previously treated Adult T-cell Leukemia-Lymphoma; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1
This entry notes the completed status of a clinical trial studying adult T-cell leukemia/lymphoma in carriers of HTLV-1.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis
This completed NCI-supported trial examined familial and genetic factors in HTLV-1–related diseases, including adult T-cell leukemia/lymphom…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Dual Algorithm Post Market Clinical Study
Post-market clinical study update for MP Biomedicals' Dual Algorithm evaluating its use in HTLV-I and HTLV-II infections and related HTLV-1 …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 [Phase 2]
This clinical trial update reports completion of a multicenter, randomized Phase 2 study comparing mLSG15 plus KW-0761 (mogamulizumab) versu…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated the combination of EPOCH chemotherapy and bortezomib in adults with adult T-cell leukemia/lym…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) [Phase 3]
A Phase 3 study evaluating treatment for aggressive Adult T-cell leukemia/lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Lenalidomide in HTLV-1 Adult T-Cell Leukemia [Phase 2]
This report notes the completion of a Phase 2 trial evaluating lenalidomide in adults with HTLV-1–associated adult T-cell leukemia/lymphoma,…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial sponsored by the National Cancer Institute evaluated alisertib for relapsed or refractory peripheral T-cell non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma [Phase 2]
This Phase 2 clinical trial evaluates a sequence of chemotherapy followed by antiviral therapy and interferon alfa in patients with HTLV-1-r…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma [Phase 2]
A Phase 2 trial evaluated lenalidomide in patients with relapsed or recurrent Adult T-cell leukemia/lymphoma. The study has completed and re…
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating sorafenib tosylate in patients with recurrent aggressive non-Hodgkin lymphomas has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma [Phase 4]
A Phase 4 trial evaluating zidovudine, interferon alfa-2b, and PEG-interferon alfa-2b in HTLV-I-associated adult T-cell leukemia/lymphoma wa…
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy [EARLY_Phase 1]
A Phase 1 study evaluating the safety and tolerability of combining sirolimus with Hyper-CVAD chemotherapy in adults with lymphoid malignanc…
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma [Phase 1]
Phase 1 study evaluating the combination of bortezomib and azacitidine in adults with relapsed or refractory T-cell lymphomas; the trial is …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma [Phase 2]
A Phase 2 trial investigating 506U78 in patients with recurrent or refractory non-Hodgkin's lymphoma and T-cell lymphomas was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: 506U78 in Treating Patients With Lymphoma [Phase 2]
Phase 2 clinical trial update on the agent 506U78 for various lymphomas; the study has completed.
-
CLINICAL_TRIALS withdrawal · 2012-11-27Clinical Trial Update: Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma [Phase 2]
This Phase 2 trial evaluating oral LBH589 (panobinostat) in patients with Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma was t…
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma [Phase 2]
A Phase II study of KW-0761 (mogamulizumab) in CCR4-positive adult T-cell leukemia-lymphoma has completed enrollment, with results posted in…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL [Phase 1]
Phase I study of KW-0761 (mogamulizumab) in relapsed CCR4-positive adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma; results ha…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas [EARLY_Phase 1]
An early-phase 1 study of lenalidomide in relapsed and/or refractory peripheral T-cell lymphomas was terminated.
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma [Phase 2]
Phase 2 clinical trial evaluating tipifarnib in relapsed or refractory lymphoma has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Evaluation of the MP Diagnostics HTLV Blot 2.4
Clinical trial update evaluating the MP Diagnostics HTLV Blot 2.4 diagnostic test for HTLV-1/HTLV-2 infections; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2011-08-22Clinical Trial Update: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) [Phase 4]
Phase 4 pilot study assessing the CHOP-daclizumab combination (CHOP-Zenapax) for HTLV-I-associated adult T-cell leukemia/lymphoma; the trial…